Literature DB >> 21786295

Open-label surgical trials for Parkinson disease: time for reconsideration.

Ron L Alterman1, Michele Tagliati, C Warren Olanow.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21786295     DOI： 10.1002/ana.22453

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  6 in total

1.  Columnar Injection for Intracerebral Cell Therapy.

Authors:  Jeffrey S Schweitzer; Bin Song; Pierre R Leblanc; Melissa Feitosa; Bob S Carter; Kwang-Soo Kim
Journal:  Oper Neurosurg (Hagerstown)       Date:  2020-03-01       Impact factor: 2.703

2.  Parkinson disease: Gene therapy for Parkinson disease--a hope, or a dream?

Authors:  C Warren Olanow
Journal:  Nat Rev Neurol       Date:  2014-03-25       Impact factor: 42.937

3.  Deep brain stimulation for the treatment of Parkinson's disease: efficacy and safety.

Authors:  Nader Pouratian; Sandeep Thakkar; Won Kim; Jeff M Bronstein
Journal:  Degener Neurol Neuromuscul Dis       Date:  2012-09-04

4.  Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.

Authors:  C Warren Olanow; Karl Kieburtz; Per Odin; Alberto J Espay; David G Standaert; Hubert H Fernandez; Arvydas Vanagunas; Ahmed A Othman; Katherine L Widnell; Weining Z Robieson; Yili Pritchett; Krai Chatamra; Janet Benesh; Robert A Lenz; Angelo Antonini
Journal:  Lancet Neurol       Date:  2013-12-20       Impact factor: 44.182

5.  Sham surgery controls in Parkinson's disease clinical trials: views of participants.

Authors:  Scott Y H Kim; Raymond De Vries; Robert G Holloway; Renee Wilson; Sonali Parnami; H Myra Kim; Samuel Frank; Karl Kieburtz
Journal:  Mov Disord       Date:  2012-08-23       Impact factor: 10.338

6.  Evidence-Based Evaluation of the Ethics of Sham Surgery for Parkinson's Disease.

Authors:  Stephen Polgar; Sheeza Mohamed
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.